Does INOTUZUMAB OZOGAMICIN Cause Platelet count decreased? 107 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Platelet count decreased have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 4.6% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
107
Reports of Platelet count decreased with INOTUZUMAB OZOGAMICIN
4.6%
of all INOTUZUMAB OZOGAMICIN reports
31
Deaths
66
Hospitalizations
How Dangerous Is Platelet count decreased From INOTUZUMAB OZOGAMICIN?
Of the 107 reports, 31 (29.0%) resulted in death, 66 (61.7%) required hospitalization, and 16 (15.0%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
Yes, Platelet count decreased is listed as a known adverse reaction in the official FDA drug label for INOTUZUMAB OZOGAMICIN.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Neoplasm progression (158)
Pyrexia (151)
Off label use (146)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Drug ineffective (92)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Platelet count decreased Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC